Volume 15, Issue 3 pp. 301-303

The Role of Skin Testing in the Use of Collagen Injectable Materials

MELVIN L. ELSON M.D.

Corresponding Author

MELVIN L. ELSON M.D.

Melvin L. Elson, M.D., is Medical Director, The Dermatology Center, Nashville, Tennessee.

Address reprint requests to Melvin L. Elson, M.D., The Dermatology Center, 4535 Harding Road, Suite 300, Nashville, TN 37205.Search for more papers by this author
First published: March 1989
Citations: 80

Abstract

Abstract. The experience of 400 consecutive patients evaluated for soft tissue augmentation for a variety of contour defects is reviewed here. The first 200 patients were evaluated with only a single skin test prior to treatment, whereas the second group were skin tested twice. The rate of hypersensitivity to the first skin test was the same in both groups, 5 out of 200 (2.5%). In the 195 patients receiving treatment after a single negative skin test, 6 (3.1%) developed hypersensitivity reactions at treatment sites. In the second group, where double skin testing was employed, an additional 7 patients had a positive second skin test (3.5%). There were no allergic reactions in the 171 patients who received treatment after two negative skin tests.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.